Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedJun 25, 2024
DataAggregated Company Financials
Companies33
  • 7D2.9%
  • 3M15.7%
  • 1Y91.3%
  • YTD14.6%

In the last week, the Pharma industry is up 2.9%, with Camurus up 1.8%. This takes the industry's 12 month performance to a gain of 91%. As for the next few years, earnings are expected to grow by 54% per annum.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 26 Jun 2024SEK 65.2bSEK 6.4b-SEK 862,355,051.0076x-75.6x10.2x
Fri, 24 May 2024SEK 53.3bSEK 6.4b-SEK 766,539,697.8170.4x-69.6x8.4x
Sun, 21 Apr 2024SEK 48.1bSEK 6.2b-SEK 1,040,638,863.1076.1x-46.2x7.7x
Tue, 19 Mar 2024SEK 50.2bSEK 6.2b-SEK 1,038,080,080.3776.2x-48.3x8x
Thu, 15 Feb 2024SEK 52.3bSEK 6.0b-SEK 909,860,292.7968.1x-57.5x8.7x
Sat, 13 Jan 2024SEK 73.1bSEK 9.5b-SEK 1,182,119,507.0071.1x-61.9x7.7x
Mon, 11 Dec 2023SEK 62.9bSEK 9.4b-SEK 1,184,542,982.0057.7x-53.1x6.7x
Wed, 08 Nov 2023SEK 53.6bSEK 9.3b-SEK 1,089,159,919.0085.4x-49.3x5.8x
Fri, 06 Oct 2023SEK 50.4bSEK 9.2b-SEK 1,177,272,519.00114x-42.8x5.5x
Sun, 03 Sep 2023SEK 51.3bSEK 9.2b-SEK 1,177,926,295.00140.3x-43.5x5.6x
Tue, 01 Aug 2023SEK 51.3bSEK 8.9b-SEK 1,413,999,763.0090.3x-36.3x5.8x
Thu, 29 Jun 2023SEK 46.7bSEK 8.4b-SEK 1,692,699,326.0078x-27.6x5.6x
Sat, 27 May 2023SEK 49.5bSEK 8.4b-SEK 1,592,285,547.0076.5x-31.1x5.9x
Mon, 24 Apr 2023SEK 46.0bSEK 8.0b-SEK 1,794,931,736.00100.6x-25.6x5.8x
Wed, 22 Mar 2023SEK 45.2bSEK 8.0b-SEK 1,793,444,143.0084.7x-25.2x5.7x
Fri, 17 Feb 2023SEK 44.4bSEK 7.3b-SEK 1,954,823,899.00278.8x-22.7x6.1x
Sun, 15 Jan 2023SEK 49.3bSEK 7.3b-SEK 1,912,940,461.00290.4x-25.8x6.8x
Tue, 13 Dec 2022SEK 49.3bSEK 7.3b-SEK 1,875,811,610.00288.6x-26.3x6.8x
Thu, 10 Nov 2022SEK 49.9bSEK 7.0b-SEK 1,732,066,395.0047.7x-28.8x7.1x
Sat, 08 Oct 2022SEK 49.3bSEK 7.0b-SEK 1,739,746,392.0048.2x-28.3x7.1x
Mon, 05 Sep 2022SEK 51.9bSEK 7.0b-SEK 1,737,402,394.0057.9x-29.9x7.4x
Wed, 03 Aug 2022SEK 52.6bSEK 6.9b-SEK 1,535,207,758.0040.7x-34.2x7.6x
Fri, 01 Jul 2022SEK 51.6bSEK 5.9b-SEK 1,509,116,648.0042.4x-34.2x8.7x
Sun, 29 May 2022SEK 54.0bSEK 5.7b-SEK 1,488,193,181.0047.3x-36.3x9.5x
Tue, 26 Apr 2022SEK 55.9bSEK 5.5b-SEK 1,335,933,728.0036.1x-41.8x10.1x
Thu, 24 Mar 2022SEK 52.2bSEK 5.4b-SEK 1,372,758,723.0038.6x-38x9.7x
Sat, 19 Feb 2022SEK 49.0bSEK 5.3b-SEK 1,059,925,675.00126.2x-46.2x9.2x
Mon, 17 Jan 2022SEK 51.2bSEK 5.5b-SEK 1,100,130,266.00121.3x-46.5x9.4x
Wed, 15 Dec 2021SEK 54.7bSEK 5.5b-SEK 1,096,912,912.00116.8x-49.8x10x
Fri, 12 Nov 2021SEK 54.6bSEK 5.0b-SEK 1,425,640,560.00127.6x-38.3x10.8x
Sun, 10 Oct 2021SEK 51.6bSEK 4.8b-SEK 1,582,214,919.00143.2x-32.6x10.8x
Tue, 07 Sep 2021SEK 58.3bSEK 4.8b-SEK 1,560,489,765.26160.7x-37.3x12.2x
Thu, 05 Aug 2021SEK 54.7bSEK 4.8b-SEK 1,412,039,942.26165.5x-38.8x11.4x
Price to Earnings Ratio

-38.2x


Total Market Cap: SEK 54.0bTotal Earnings: -SEK 1,412,039,942.26Total Revenue: SEK 4.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -39.5x202220232024
Current Industry PE
  • Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 8.0x is lower than the industry's current PS ratio of 10.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Revenues for these companies have grown 10.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market1.37%
Healthcare0.89%
Pharma2.89%
Pharma2.89%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 583.004.2%
+SEK 1.4b		116.9%PE75.8x
SECARE SwedencareSEK 62.055.2%
+SEK 484.1m		65.2%PE137.8x
DICOT Dicot PharmaSEK 0.4937.6%
+SEK 110.4m		169.9%PB13.1x
MOB Moberg PharmaSEK 30.0414.6%
+SEK 106.8m		54.2%PS1024.3x
ANNX Annexin PharmaceuticalsSEK 0.5726.9%
+SEK 41.9m		-37.5%PB31.1x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

MOB

SEK 30.04

Moberg Pharma

7D

14.6%

1Y

54.2%

ORX

SEK 21.30

Orexo

7D

-1.2%

1Y

135.1%

CALTX

SEK 205.00

Calliditas Therapeutics

7D

0.2%

1Y

140.6%

KDEV

SEK 1.45

Karolinska Development

7D

-2.4%

1Y

-14.4%

DICOT

SEK 0.49

Dicot Pharma

7D

37.6%

1Y

169.9%

ODI

SEK 7.35

ODI Pharma

7D

-5.8%

1Y

34.9%

CSMED

DKK 4.76

CS Medica

7D

-4.5%

1Y

-48.8%

CS Medica (NGM:CSMED) Is Making Moderate Use Of Debt

Jun 04
CS Medica (NGM:CSMED) Is Making Moderate Use Of Debt

CAMX

SEK 583.00

Camurus

7D

4.2%

1Y

116.9%

ERMA

SEK 3.05

Enorama Pharma

7D

27.1%

1Y

3.7%

IBT B

SEK 96.00

Infant Bacterial Therapeutics

7D

-4.5%

1Y

101.7%

CLBIO

SEK 12.50

Corline Biomedical

7D

-4.2%

1Y

-16.7%

ECTIN B

SEK 0.28

Ectin Research

7D

-44.4%

1Y

-42.0%

ANNX

SEK 0.57

Annexin Pharmaceuticals

7D

26.9%

1Y

-37.5%

SECARE

SEK 62.05

Swedencare

7D

5.2%

1Y

65.2%

PILA

SEK 4.61

Pila Pharma

7D

32.5%

1Y

94.5%